73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Brain boost: Can a coach help elders at risk for Alzheimer's?

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San
Research examines how to stay on task

Research examines how to stay on task

by University of Texas at ArlingtonTask paradigm visual for a single trial on the four-choice reaction time task. Credit:Attention, Perception, & Psychophysics(2023). DOI: 10.3758

Research examines how to stay on task

by University of Texas at ArlingtonTask paradigm visual for a single trial on the four-choice reaction time task. Credit:Attention, Perception, & Psychophysics(2023). DOI: 10.3758
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Study: Mitochondria engage the integrated stress response to promote tumor growth

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot
Pancreatic cancer tumor classification could optimize treatment choices

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli
Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

by St. Jude Children's Research HospitalInvestigators at St. Jude Children's Research Hospital have linked inherited BRCA2 gene mutations with an increased risk of non-Hodgkin lymphoma in

Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

by St. Jude Children's Research HospitalInvestigators at St. Jude Children's Research Hospital have linked inherited BRCA2 gene mutations with an increased risk of non-Hodgkin lymphoma in
EU approves treatment for prostate cancer

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The
Trial finds high-dose radiation effective for men whose prostate cancer has spread

Trial finds high-dose radiation effective for men whose prostate cancer has spread

by American Society for Radiation OncologyCredit: ASTROA randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an e

Trial finds high-dose radiation effective for men whose prostate cancer has spread

by American Society for Radiation OncologyCredit: ASTROA randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an e
'Bet hedging' explains the efficacy of many combination cancer therapies

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat
Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainA meta-analysis of studies involving 33,541 cancer patients evaluates the relationship between advance care planning and aggressive vs. co

Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainA meta-analysis of studies involving 33,541 cancer patients evaluates the relationship between advance care planning and aggressive vs. co
New molecular blocker halts breast cancer metastasis, says study

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On